Table 4.

Summary of Ongoing Clinical Trials.

Trial	Author	n	Population	Intervention (mg)	Duration	Measured Endpoints	Result	Ref
ALL-HEART	Mackenzie et al.	5,215	Ischemic Heart Disease	Allopurinol up to 600 mg daily vs. No treatment	4 years	Composite of non-fatal myocardial infarction, non-fatal stroke or cardiovascular death.	Patient recruitment began in February 2014 with ongoing data collection and follow-up	[103]
LEAF-CHF	Yokota et al.	200	Chronic HF with Hyperuricemia	Febuxostat 60 mg vs. Control	24 weeks	Change in plasma BNP levels.	Results Pending with ongoing data collection and follow-up	[123]